Research Institute for Liver Diseases (Shanghai) Co., Ltd. is a biotechnology research and development enterprise founded by returned overseas experts in Zhangjiang High-tech Park, Shanghai in 2002.

We apply in vitro biotechnology as a platform, strictly follow the corresponding guiding principles of the pharmaceutical administration, relevant medical ethics and animal rights, fully implement quality monitoring, and provide the new drug innovation team with more, faster, better and more efficient in vitro drug ADMET evaluation services and products.